The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...

In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase inhibitors (PARPi) have ...

Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the 'dark ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

A new study describes a key molecular mechanism that explains how cells exchange information through extracellular vesicles (EVs), small particles with great therapeutic potential. The results, ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics. Click here to read our picks.